|
|
||||||||
Intestinal Disease Research Programme, McMaster University, Hamilton, Ontario L8N 3Z5, Canada
The association between oral contraceptives
or pregnancy and inflammatory bowel disease is unclear. We investigated
whether 17
-estradiol modulates intestinal inflammation in two models of colitis. Female mice were treated with 17
-estradiol alone or with
tamoxifen, tamoxifen alone, 17
-estradiol, or placebo. Dinitrobenzene
sulfonic acid (DNB)- or dextran sodium sulfate (DSS)-induced colitis
were assessed macroscopically, histologically, and by myeloperoxidase
(MPO) activity. Malondialdehyde and mRNA levels of intercellular
adhesion molecule-1 (ICAM-1), interferon-
(IFN-
), and
interleukin-13 (IL-13) were determined. In DNB colitis, 17
-estradiol
alone, but not 17
-estradiol plus tamoxifen, or 17
-estradiol
reduced macroscopic and histological scores, MPO activity and
malondialdehyde levels. 17
-Estradiol also decreased the expression
of ICAM-1, IFN-
, and IL-13 mRNA levels compared with placebo. In
contrast, 17
-Estradiol increased the macroscopic and histological
scores compared with placebo in mice with DSS colitis. These results
demonstrate anti-inflammatory and proinflammatory effects of
17
-estradiol in two different models of experimental colitis. The
net modulatory effect most likely reflects a combination of estrogen
receptor-mediated effects and antioxidant activity and may explain, in
part, conflicting results from clinical trials.
inflammation; antioxidant activity; sex steroids
This article has been cited by other articles:
![]() |
V. Braniste, M. Leveque, C. Buisson-Brenac, L. Bueno, J. Fioramonti, and E. Houdeau Oestradiol decreases colonic permeability through oestrogen receptor \#946;-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells J. Physiol., July 1, 2009; 587(13): 3317 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
E F Verdu, P Bercik, M Verma-Gandhu, X-X Huang, P Blennerhassett, W Jackson, Y Mao, L Wang, F Rochat, and S M Collins Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice Gut, February 1, 2006; 55(2): 182 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Motomura, H. Kanbayashi, W. I. Khan, Y. Deng, P. A. Blennerhassett, P. J. Margetts, J. Gauldie, K. Egashira, and S. M. Collins The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-{beta} type II receptor gene transfer Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G143 - G150. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Harnish, L. M. Albert, Y. Leathurby, A. M. Eckert, A. Ciarletta, M. Kasaian, and J. C. Keith Jr. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G118 - G125. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, Y. Fan, and D. H. Teitelbaum Intraepithelial lymphocyte-derived interferon-gamma evokes enterocyte apoptosis with parenteral nutrition in mice Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G629 - G637. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |